Product Information

CIMETIDINE 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2021 per EA under NDC 59651082301. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Nov 12, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CIMETIDINE 200 MG TABLET

CIMETIDINE
$0.2021per EA

Strength

200 mg/1

NDC

59651082301

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CIMETIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA218997

FDA Approved

11/12/2024

TE Code

AB

On Market Since

11/12/2024

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price Statistics

The NADAC for CIMETIDINE 200 MG TABLET has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 14.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2021 per EA
All-time high$0.2435 (Oct 15, 2025)
All-time low$0.2021 (Nov 18, 2026)
52-week high$0.2299
52-week low$0.2021
Median price$0.2140
Average price$0.2198
Largest weekly change-5.1% (Dec 17, 2025)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

-1.2%

1M

-1.0%

3M

-3.3%

6M

-5.3%

1Y

-16.5%

3Y

N/A

5Y

N/A

All

-14.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CIMETIDINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2021 per EA (NDC 59651082301), effective Nov 18, 2026.

How has the price of CIMETIDINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for CIMETIDINE 200 MG TABLET has declined 14.9%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for CIMETIDINE 200 MG TABLET?

Since Jun 11, 2025, the NADAC for CIMETIDINE 200 MG TABLET has ranged from a low of $0.2021 (Nov 18, 2026) to a high of $0.2435 (Oct 15, 2025), with a median of $0.2140 per EA.

Are there cheaper alternatives to CIMETIDINE 200 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIMETIDINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CIMETIDINE 200 MG TABLET?

CIMETIDINE 200 MG TABLET (NDC 59651082301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.